These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 38685363)
1. Molecular mechanisms of Asparagus racemosus willd. and Withania somnifera (L.) Dunal as chemotherapeutic adjuvants for breast cancer treatment. Prasad K; Saggam A; Guruprasad KP; Tillu G; Patwardhan B; Satyamoorthy K J Ethnopharmacol; 2024 Sep; 331():118261. PubMed ID: 38685363 [TBL] [Abstract][Full Text] [Related]
2. Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression. Saggam A; Kale P; Shengule S; Patil D; Gautam M; Tillu G; Joshi K; Gairola S; Patwardhan B Front Pharmacol; 2022; 13():835616. PubMed ID: 35273508 [TBL] [Abstract][Full Text] [Related]
3. Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer. Saggam A; Tillu G; Dixit S; Chavan-Gautam P; Borse S; Joshi K; Patwardhan B J Ethnopharmacol; 2020 Jun; 255():112759. PubMed ID: 32173425 [TBL] [Abstract][Full Text] [Related]
4. Immunoprotection by botanical drugs in cancer chemotherapy. Diwanay S; Chitre D; Patwardhan B J Ethnopharmacol; 2004 Jan; 90(1):49-55. PubMed ID: 14698508 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells. Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653 [TBL] [Abstract][Full Text] [Related]
6. Keeping abreast about ashwagandha in breast cancer. Vashi R; Patel BM; Goyal RK J Ethnopharmacol; 2021 Apr; 269():113759. PubMed ID: 33359916 [TBL] [Abstract][Full Text] [Related]
7. Effect of Withania somnifera (L.) Dunal aqueous root extract on reinstatement using conditioned place preference and brain GABA and dopamine levels in alcohol dependent animals. Marathe PA; Satam SD; Raut SB; Shetty YC; Pooja SG; Raut AA; Kale PP; Rege NN J Ethnopharmacol; 2021 Jun; 274():113304. PubMed ID: 32920131 [TBL] [Abstract][Full Text] [Related]
8. An update on existing therapeutic options and status of novel anti-metastatic agents in breast cancer: Elucidating the molecular mechanisms underlying the pleiotropic action of Withania somnifera (Indian ginseng) in breast cancer attenuation. Srivastava A; Ahmad R; Yadav K; Siddiqui S; Trivedi A; Misra A; Mehrotra S; Ahmad B; Ali Khan M Int Immunopharmacol; 2024 Jul; 136():112232. PubMed ID: 38815352 [TBL] [Abstract][Full Text] [Related]
9. Antiulcer and antioxidant activity of Asparagus racemosus Willd and Withania somnifera Dunal in rats. Bhatnagar M; Sisodia SS; Bhatnagar R Ann N Y Acad Sci; 2005 Nov; 1056():261-78. PubMed ID: 16387694 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological potential of Rizvi ZA; Babele P; Madan U; Sadhu S; Tripathy MR; Goswami S; Mani S; Dikshit M; Awasthi A Front Immunol; 2023; 14():1138215. PubMed ID: 36960064 [TBL] [Abstract][Full Text] [Related]
11. Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis. Xue YN; Yu BB; Liu YN; Guo R; Li JL; Zhang LC; Su J; Sun LK; Li Y Prostate; 2019 May; 79(6):647-656. PubMed ID: 30714183 [TBL] [Abstract][Full Text] [Related]
12. Synergistic Anti-Tumor Effect of Toosendanin and Paclitaxel on Triple-Negative Breast Cancer via Regulating ADORA2A-EMT Related Signaling. Zhang J; Xu HX; Wu YL; Cho WCS; Xian YF; Lin ZX Adv Biol (Weinh); 2023 Aug; 7(8):e2300062. PubMed ID: 37401656 [TBL] [Abstract][Full Text] [Related]
13. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors. Lee J; Hahm ER; Marcus AI; Singh SV Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234 [TBL] [Abstract][Full Text] [Related]
14. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells. Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. Mathur R; Gupta SK; Singh N; Mathur S; Kochupillai V; Velpandian T J Ethnopharmacol; 2006 May; 105(3):336-41. PubMed ID: 16412596 [TBL] [Abstract][Full Text] [Related]
16. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT. Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718 [TBL] [Abstract][Full Text] [Related]
17. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123 [TBL] [Abstract][Full Text] [Related]
19. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines. Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732 [TBL] [Abstract][Full Text] [Related]
20. Elemene Injection Overcomes Paclitaxel Resistance in Breast Cancer through AR/RUNX1 Signal: Network Pharmacology and Experimental Validation. Gu X; Xu L; Fu Y; Fan S; Huang T; Yu J; Chen J; Sui X; Xie X Curr Pharm Des; 2024; 30(29):2313-2324. PubMed ID: 38918989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]